Semisynthesis and degradation of the tubulin inhibitors epothilone and tubulysin

被引:63
作者
Höfle, G [1 ]
Glaser, N [1 ]
Leibold, T [1 ]
Karama, U [1 ]
Sasse, F [1 ]
Steinmetz, H [1 ]
机构
[1] Gesell Biotechnol Forsch mbH, Dept Nat Prod, D-38124 Braunschweig, Germany
关键词
D O I
10.1351/pac200375020167
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The structure-activity relationships of epothilones indicate that major modifications are only tolerated in the western ring segment. In particular, C2 methyl of the thiazole ring appears to be most flexible. Its broad modification started from epothilone F, which was obtained from natural epothilone B by hydroxylation via the N-oxide. Some of the prepared derivatives exhibit improved esterase stability in addition to high cytotoxic activity. For these and other favorable properties, amine (BMS-310705) was recently introduced in clinical trials. In an alternative approach, modified side chains were introduced by replacement of the C12,C15 ring segment via ring-opening olefin metathesis (ROM) of epothilone C in the presence of ethylene to 12,13-seco-epothilone C, introduction of a synthetic building block followed by ring-closing olefin metathesis (RCM), and epoxidation to the 16-alkyne analog of epothilone A. The structure of the tetrapeptide tubulysin D was confirmed by total hydrolysis to N-methyl D-pipecolic acid, L-isoleucine, tubuvaline (Tuv), tubuphenylalanine (Tup), formaldehyde, and 3-methylbutyric acid. Mild acidic hydrolysis to cyclo-tubulysin and oxidative degradation to L-valine allowed the assignment of the stereocenters of Tuv, hydrazinolysis, and comparison with synthetic reference samples to that of Tup. The absolute configuration of tubulysin D is: (R)-Mep, (2S,3S)-Ile, (1'R,3'R)-Tuv, and (2S,4R)-Tup.
引用
收藏
页码:167 / 178
页数:12
相关论文
共 57 条
[1]  
Altmann KH, 2000, CHIMIA, V54, P612
[2]  
[Anonymous], [No title captured], Patent No. [DE 4138042, 4138042]
[3]   DOLASTATIN-15, A POTENT ANTIMITOTIC DEPSIPEPTIDE DERIVED FROM DOLABELLA-AURICULARIA - INTERACTION WITH TUBULIN AND EFFECTS ON CELLULAR MICROTUBULES [J].
BAI, R ;
FRIEDMAN, SJ ;
PETTIT, GR ;
HAMEL, E .
BIOCHEMICAL PHARMACOLOGY, 1992, 43 (12) :2637-2645
[4]  
BOLLAG DM, 1995, CANCER RES, V55, P2325
[5]   A novel application of a Pd(0)-catalyzed nucleophilic substitution reaction to the regio- and stereoselective synthesis of lactam analogues of the epothilone natural products [J].
Borzilleri, RM ;
Zheng, XP ;
Schmidt, RJ ;
Johnson, JA ;
Kim, SH ;
DiMarco, JD ;
Fairchild, CR ;
Gougoutas, JZ ;
Lee, FYF ;
Long, BH ;
Vite, GD .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2000, 122 (37) :8890-8897
[6]  
BRISTOL MYERS SQUIBB, 2002, Patent No. 63996381
[7]  
BROZILLERI RM, 2003, DRUGS FUTURE, V27, P1149
[8]   Epothilones and their analogues -: a new class of promising microtubule inhibitors [J].
Flörsheimer, A ;
Altmann, KH .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2001, 11 (06) :951-968
[9]   Studies on the biosynthesis of epothilones:: Hydroxylation of Epo A and B to epothilones E and F [J].
Gerth, K ;
Steinmetz, H ;
Höfle, G ;
Reichenbach, H .
JOURNAL OF ANTIBIOTICS, 2002, 55 (01) :41-45
[10]   Epothilons A and B: Antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria) - Production, physico-chemical and biological properties [J].
Gerth, K ;
Bedorf, N ;
Hofle, G ;
Irschik, H ;
Reichenbach, H .
JOURNAL OF ANTIBIOTICS, 1996, 49 (06) :560-563